Home Apoptosis Bcl-2 inhibitor ABT-737

research use only

ABT-737 Bcl-2 Inhibitor

Cat.No.S1002

ABT-737 is a BH3 mimetic inhibitor of Bcl-xL, Bcl-2 and Bcl-w with EC50 of 78.7 nM, 30.3 nM and 197.8 nM in cell-free assays, respectively; no inhibition observed against Mcl-1, Bcl-B or Bfl-1. ABT-737 induces mitochondrial pathway apoptosis and mitophagy. Phase 2.
ABT-737 Bcl-2 inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 813.43

Jump to

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about ABT-737 working concentrations for cell culture treatment

×

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about ABT-737

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
What is the recommended method for reconstituting it for in vivo animal study?

Answer:
For oral administration, we suggest the vehicle: 30% Propylene glycol, 5% Tween 80, 65% D5W, at up to 30mg/ml; For injection, it can be dissolved in 2% DMSO/50% PEG 300/5% Tween 80/ddH2O at 2.5 mg/ml.